1H-Thieno[2,3-d][1,3]oxazine-2,4-dione, 95.0%, 250mg

1-[4-(cyclopentylamino)-2-(methylsulfanyl)pyrimidin-5-yl]ethan-1-one, 98%, 100mg

tert-Butyl (4-ethylpiperidin-4-yl)carbamate, 95.0%, 100mg

1-TERT-BUTYL 2-METHYL 5-CYANOPYRROLIDINE-1,2-DICARBOXYLATE, 95.0%, 2g

Methyl5-fluoro-6-hydroxy-naphthalene-1-carboxylate, 98%, 500mg

Benzyl (2S)-4-(7-(8-chloronaphthalen-1-yl)-2-(methylsulfinyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)-2-(cyanomethyl)piperazine-1-carboxylate, 97%, 1g

4-bromo-N-methyl-N-phenylbenzenesulfonamide, 95%, 100mg

Methyl 8-bromoquinoline-2-carboxylate, 98%, 10g

8-CHLORO-CHROMAN-4-YLAMINE, 95.0%, 250mg

(S)-5-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine (S)-2-hydroxy-2-phenylacetate, 98%, 1g

Xanthene-9-carboxylic Acid>98.0%(T)25g

Infinitely corrected plan PL 4x/0.10 IOS objective. Working distance 11.9 mm

4-(Hydroxymethyl)bicyclo[2.2.1]heptane-1-carboxylic acid, 98%, 1g